Suppr超能文献

需要住院治疗的糖尿病足感染患者中耐甲氧西林金黄色葡萄球菌和产超广谱β-内酰胺酶肠杆菌科的危险因素。

Risk factors for methicillin-resistant Staphylococcus aureus and extended-spectrum ß-lactamase producing Enterobacterales in patients with diabetic foot infections requiring hospital admission.

机构信息

Joaquín Gómez Gómez, Hospital Clínico Universitario Virgen de la Arrixaca, Ctra. Madrid-Cartagena s/n, 30120, El Palmar, Murcia, Spain.

José Barberán, Hospital Universitario HM Montepríncipe, Avda. Montepríncipe 25, 28660 Boadilla del Monte, Madrid, Spain.

出版信息

Rev Esp Quimioter. 2020 Dec;33(6):430-435. doi: 10.37201/req/101.2020. Epub 2020 Nov 27.

Abstract

OBJECTIVE

Methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) may complicate the treatment of diabetic foot infections (DFIs). The aim of this study was to determine the risk factors for these pathogens in DFIs.

METHODS

This was a prospective observational study of 167 consecutive adult patients with DFIs. The diagnosis and severity of DFIs were based on the Infectious Disease Society of America (IDSA) classification system. Multivariate analyses were performed in order to identify risk factors for MRSA and ESBL-E infections.

RESULTS

S. aureus was the most isolated pathogen (n=82, 37.9 %) followed by Escherichia coli (n= 40, 18.5%). MRSA accounted for 57.3% of all S. aureus and 70% of Klebsiella pneumoniae and 25% of E. coli were ESBL producers, respectively. Deep ulcer [OR 8,563; 95% CI (1,068-4,727)], previous use of fluoroquinolones [OR 2,78; 95% CI (1,156-6,685)] and peripheral vasculopathy [OR 2,47; 95% CI (1.068-4.727)] were the independent predictors for MRSA infections; and osteomyelitis [OR 6,351; 95% CI (1,609-25,068)] and previous use of cephalosporins [OR 5,824; 95% CI (1,517-22,361)] for ESBL-E infections.

CONCLUSIONS

MRSA and ESBL-E have adquired a great clinical relevance in DFIs. The availability of their risk factors is very convenient to choose the empirical treatment in severe forms.

摘要

目的

耐甲氧西林金黄色葡萄球菌(MRSA)和产超广谱β-内酰胺酶肠杆菌科(ESBL-E)可使糖尿病足感染(DFIs)的治疗复杂化。本研究旨在确定 DFIs 中这些病原体的危险因素。

方法

这是一项对 167 例连续成年 DFI 患者的前瞻性观察性研究。DFIs 的诊断和严重程度基于美国传染病学会(IDSA)分类系统。进行了多变量分析以确定 MRSA 和 ESBL-E 感染的危险因素。

结果

金黄色葡萄球菌是最常见的分离病原体(n=82,37.9%),其次是大肠杆菌(n=40,18.5%)。MRSA 占所有金黄色葡萄球菌的 57.3%,肺炎克雷伯菌的 70%和 25%的大肠杆菌为 ESBL 产生菌。深部溃疡[OR 8.563;95%CI(1.068-4.727)]、氟喹诺酮类药物的既往使用[OR 2.78;95%CI(1.156-6.685)]和周围血管病[OR 2.47;95%CI(1.068-4.727)]是 MRSA 感染的独立预测因子;骨髓炎[OR 6.351;95%CI(1.609-25.068)]和头孢菌素类药物的既往使用[OR 5.824;95%CI(1.517-22.361)]是 ESBL-E 感染的独立预测因子。

结论

MRSA 和 ESBL-E 在 DFIs 中具有重要的临床相关性。这些危险因素的存在非常方便选择严重形式的经验性治疗。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验